US Stock Moves: Zai Lab Shares Surge Over 10% Extending Two-Day Rally

Stock News

Aug 07

Following a more than 13% jump in the previous session, Zai Lab Ltd (ZLAB.US) shares continued to climb sharply on Friday, rising over 10% to $23.03.

According to market sources, Citigroup released a report noting that Zai Lab's second-quarter product revenue improved approximately 11% quarter-over-quarter to about $106 million, aligning with the bank's and market expectations. This performance has boosted Citigroup's confidence that the company's China operations can stabilize by the second half of 2026 and resume significant growth by 2027, as per management guidance. The bank has raised its price target for Zai Lab's US-listed shares from $44 to $45.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1195949749"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195949749\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195949749?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195949749","market":"nz","top_or_hot":-1,"title":"US Stock Moves: Zai Lab Shares Surge Over 10% Extending Two-Day Rally","media":"Stock News","content":"<p>Following a more than 13% jump in the previous session, <b>Zai Lab Ltd</b> (<b>ZLAB.US</b>) shares continued to climb sharply on Friday, rising over 10% to $23.03.<br><br>According to market sources, Citigroup released a report noting that <b>Zai Lab's</b> second-quarter product revenue improved approximately 11% quarter-over-quarter to about $106 million, aligning with the bank's and market expectations. This performance has boosted Citigroup's confidence that the company's China operations can stabilize by the second half of 2026 and resume significant growth by 2027, as per management guidance. The bank has raised its price target for <b>Zai Lab's</b> US-listed shares from $44 to $45.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US Stock Moves: Zai Lab Shares Surge Over 10% Extending Two-Day Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS Stock Moves: Zai Lab Shares Surge Over 10% Extending Two-Day Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-07 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Following a more than 13% jump in the previous session, <b>Zai Lab Ltd</b> (<b>ZLAB.US</b>) shares continued to climb sharply on Friday, rising over 10% to $23.03.<br><br>According to market sources, Citigroup released a report noting that <b>Zai Lab's</b> second-quarter product revenue improved approximately 11% quarter-over-quarter to about $106 million, aligning with the bank's and market expectations. This performance has boosted Citigroup's confidence that the company's China operations can stabilize by the second half of 2026 and resume significant growth by 2027, as per management guidance. The bank has raised its price target for <b>Zai Lab's</b> US-listed shares from $44 to $45.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"","article_id":"1195949749","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195949749","pubTimestamp":1786111815,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Following a more than 13% jump in the previous session, Zai Lab Ltd (ZLAB.US) shares continued to climb sharply on Friday, rising over 10% to $23.03.According to market sources, Citigroup released a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK1161":"生物科技","BK1588":"回港中概股","BK4526":"热门中概股","BK1574":"生物医药B类股","ZLAB":"再鼎医药","BK4548":"巴美列捷福持仓","09688":"再鼎医药","BK4139":"生物科技","BK4531":"中概回港概念","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK4588":"碎股"},"translate_title":"美股走势：再鼎医药股价飙升逾10%，延续两日涨势","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1,"ZLAB":1},"content_text":"Following a more than 13% jump in the previous session, Zai Lab Ltd (ZLAB.US) shares continued to climb sharply on Friday, rising over 10% to $23.03.According to market sources, Citigroup released a report noting that Zai Lab's second-quarter product revenue improved approximately 11% quarter-over-quarter to about $106 million, aligning with the bank's and market expectations. This performance has boosted Citigroup's confidence that the company's China operations can stabilize by the second half of 2026 and resume significant growth by 2027, as per management guidance. The bank has raised its price target for Zai Lab's US-listed shares from $44 to $45.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}